Related Experiment Video
Updated: Jul 2, 2026
05:17
Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
Heparin overdose scare in 14 babies at Texas hospital
Healthcare Benchmarks and Quality Improvement
|August 30, 2008
Insights
Accurate medication dosing for children requires weighing them in kilograms. Thoroughly testing computerized provider order entry (CPOE) systems before implementation is crucial for safe pediatric prescribing.
Area of Science:
- Pediatric pharmacology
- Clinical informatics
Background:
- Pediatric medication dosing presents unique challenges compared to adults.
- Ensuring accurate drug administration in children is critical for patient safety and treatment efficacy.
Purpose of the Study:
- To highlight key considerations for safe medication dosing in pediatric patients.
- To emphasize the importance of accurate weight measurement and system implementation for pediatric prescribing.
Main Methods:
- Review of best practices in pediatric pharmacotherapy.
- Guidance on utilizing clinical decision support tools and electronic prescribing systems.
Main Results:
- Accurate pediatric medication dosing necessitates using patient weight in kilograms.
- Thorough validation of computerized provider order entry (CPOE) systems is essential prior to clinical use.
Conclusions:
- Standardizing weight measurement to kilograms is a fundamental step in safe pediatric medication management.
- Effective implementation of CPOE systems requires comprehensive pre-implementation testing to prevent errors.
Abstract:
* Properly dosing meds for pediatric patients involves unique challenges. * All children for whom medication is being prescribed should be weighed in kilograms. * Be sure to test out your CPOE system thoroughly before starting implementation.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...